FTSE 100 6771.09 -0.07%

Pharmaceuticals

The company's shares have lost almost three quarters of their value over the last 12 months

Valeant share price slumps as charges against former exec revealed
Hayley Kirton
Hayley Kirton | Staff

Wearable digital healthtech startup shows positive vital signs
Steve Vance
Steve Vance | Invest Edinburgh

Hikma Pharmaceuticals has cut its full year sales guidance
Billy Bambrough
Billy Bambrough | Staff

Astrazeneca profits slide after increased competition

Natasha Clark
Natasha Clark | Staff

Pharma firm share prices are jumping on Trump's win. Here's why

Billy Bambrough
Billy Bambrough | Staff

CVS shares slide after cuts to its full-year profit expectations

Billy Bambrough
Billy Bambrough | Staff

Valeant shares slump as full-year guidance is slashed and losses mount

Billy Bambrough
Billy Bambrough | Staff

Crestor competition expected to drag on AstraZeneca interim results
Billy Bambrough
Billy Bambrough | Staff

GW Pharmaceuticals and British Sugar sign cannabis plant deal
Billy Bambrough
Billy Bambrough | Staff

Vaccine and cancer drug sales give pharma firm Merck a boost

Billy Bambrough
Billy Bambrough | Staff

Large-cap pharma firms top global ranking of firms creating value

Billy Bambrough
Billy Bambrough | Staff

NHS trusts eye £5bn savings in supply chain deal

Billy Bambrough
Billy Bambrough | Staff

How tech firm Dexcom is disrupting healthcare management

Judy Law
Judy Law | Invest Edinburgh

Weak pound gives UK's cosmetic surgery sector a facelift
Francesca Washtell
Francesca Washtell | Staff

Pharmaceuticals: Most viewed

snap40 was set up by Chris McCann (centre) in 2014 as a medical student

Wearable digital healthtech startup shows positive vital signs
Steve Vance
Steve Vance | Invest Edinburgh

Valeant share price slumps as charges against former exec revealed
Hayley Kirton
Hayley Kirton | Staff